Processing. Please wait...

Sangamo Short Ratio

$10.35  0.50  4.61%
Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Short Ratio 
Short Interest 
Average Trading Volume 
11.00 times

About Short Ratio

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare Sangamo to competition

Sangamo Short Ratio Assessment

Benchmark  Embed   Sangamo Comparables 
Based on latest financial disclosure Sangamo Biosciences Inc has Short Ratio of 11.0 times. This is 170.94% higher than that of the Healthcare sector, and 175.0% higher than that of Biotechnology industry, The Short Ratio for all stocks is 431.4% lower than the firm.

Filter other Stocks by Short Ratio

Short Ratio Input Range 
Click to run this filter
 Run Equity Filter
Filter Other Equities
Found 10 equities

Short Ratio

GILD NMSGilead Sciences Inc
5.1 times
2.5 times
BIIB NMSBiogen Idec Inc
1.4 times
CELG NMSCelgene Corporation
2.9 times
REGN NMSRegeneron Pharmaceuticals Inc
5.5 times
ALXN NMSAlexion Pharmaceuticals Inc
3.0 times
VRTX NMSVertex Pharmaceuticals Incorporated
2.8 times
ILMN NMSIllumina Inc
2.6 times
BMRN NMSBioMarin Pharmaceutical Inc
2.7 times
INCY NMSIncyte Corporation
4.7 times
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Sangamo is currently under evaluation in short ratio category among related companies.
Benchmark  Embed   Sangamo Comparables 
NameSangamo Biosciences Inc
InstrumentUSA Stock
Analyst ConsensusStrong Buy 6 Opinions
Risk-adjusted AdviceCautious Hold Under Valued
CurrencyUSD - US Dollar
DescriptionSangamo BioSciences Inc. a clinical stage biopharmaceutical company focuses on the research development and commercialization of engineered DNAbinding proteins as novel therapeutic solutions for unmet medical needs in the United States. more

Other Sangamo Fundamentals

Return On Equity(11.37) %
Return On Asset(6.35) %
Profit Margin(47.15) %
Operating Margin(48.96) %
Current Valuation638.39 M
Shares Outstanding69.58 M
Shares Owned by Insiders3.08 %
Shares Owned by Institutions77.20 %
Number of Shares Shorted8.67 M
Price to Book4.12 times
Price to Sales16.70 times
Revenue51.24 M
Gross Profit45.87 M
EBITDA(24.52 M)
Net Income(24.16 M)
Cash and Equivalents195.9 M
Cash per Share2.82 times
Current Ratio10.21 times
Book Value Per Share2.99 times
Cash Flow from Operations(19.45 M)
Short Ratio11.00 times
One Year High19.25
One Year Low9.39
Earnings Per Share(0.35) times
Number of Employees102
Market Capitalization834.3 M
Total Asset238.5 M
Retained Earnings(333.87 M)
Working Capital119.14 M
Current Asset203.95 M
Current Liabilities19.97 M
Z Score-1.4